GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » iRadimed Corp (FRA:46K) » Definitions » 3-Year EPS without NRI Growth Rate

iRadimed (FRA:46K) 3-Year EPS without NRI Growth Rate : 30.80% (As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is iRadimed 3-Year EPS without NRI Growth Rate?

iRadimed's EPS without NRI for the three months ended in Dec. 2024 was €0.42.

During the past 12 months, iRadimed's average EPS without NRI Growth Rate was 12.20% per year. During the past 3 years, the average EPS without NRI Growth Rate was 30.80% per year. During the past 5 years, the average EPS without NRI Growth Rate was 40.50% per year. During the past 10 years, the average EPS without NRI Growth Rate was 19.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of iRadimed was 137.80% per year. The lowest was -41.30% per year. And the median was 21.55% per year.


Competitive Comparison of iRadimed's 3-Year EPS without NRI Growth Rate

For the Medical Devices subindustry, iRadimed's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


iRadimed's 3-Year EPS without NRI Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, iRadimed's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where iRadimed's 3-Year EPS without NRI Growth Rate falls into.



iRadimed 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


iRadimed  (FRA:46K) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


iRadimed 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of iRadimed's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


iRadimed Business Description

Traded in Other Exchanges
Address
1025 Willa Springs Drive, Winter Springs, FL, USA, 32708
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.

iRadimed Headlines

No Headlines